Tibor Keler

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Marina Caskey, Florian Klein, Julio C. C. Lorenzi et al. · Nature · 2015 · 752 citations · Full text

Human Retrovirus, Antibody 3Bnc117, Immunology +7

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey, Till Schoofs, Henning Gruell et al. · Nature Medicine · 2017 · 491 citations

Hiv-1-infected Individuals, Human Retrovirus, Immunology +7

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Johannes F. Scheid, Joshua A. Horwitz, Yotam Bar‐On et al. · Nature · 2016 · 464 citations · Full text

Viral Persistence, Human Retrovirus, Immunology +10

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Kristin M. Sanderson, Ronald Scotland, Peter P. Lee et al. · Journal of Clinical Oncology · 2004 · 433 citations